Flavonoids content of 70% methanolic extract of Erucaria pinnata (Viv.) and its effect as anticancer and antiangiognic: in vitro, in vivo and docking study
Article Sidebar
-
antiangeogenic activity, carbontetrachloride, chemopreventive, diethylnitrosamine, Erucaria pinnata, hepatocellularcarcinoma
Abstract
Erucaria pinnata (Viv.) is a wild annual plant growing in North-Western Coastal Region in Egypt. This study reports for the first time the cytotoxic activity of different extracts of Erucaria pinnata plant against HEP-G2 cell line. The 70% methanolic extract (E1) recorded the best potent cytotoxic activity (IC50=13.6 µg/ml), so we analysis the flavonoids constituent of this extract using HPLC, which show that our extract is rich with important flavonoids compounds (rutin, quercetin, leutolin, etc.). We evaluated its antitumor activity against hepatocellular carcinoma (HCC) induced by diethylnitrosamine (DEN) (200mg/Kg. b.wt., i.p, single dose) after two weeks, animals received carbontetrachloride (CCl4) (3ml/Kg. b.wt., SC, once a week for 6 weeks) and the experiment continued for 44 weeks in rats. After the experimental period, the administration of DEN/CCl4 showed significant increase in the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bilirubin, gamma-glutamyl transferase (γGT) and significant decrease in the levels of total proteins and albumin content in the serum with reduction in the liver antioxidants, including superoxide dismutase (SOD) and catalase (CAT). This was accompanied by increases in serum specific tumor markers (AFP). The 70% methanolic plant extract (E1) was orally administrated (400mg/kg/day respectively) for the whole study period, and it showed a significant improvement at the different biological liver functions, remodeled the antioxidant enzymes activity and down-regulated the serum AFP. All these findings were confirmed by histopathological studies of the liver samples obtained from all groups.
Full text article
References
Afzal, M., Kazmi, I., Gupta, G., Rahman, M., Kimothi, V., Anwar, F. 2012. Preventive effect of Metformin against N-nitrosodiethylamine-initiated hepato- cellular carcinoma in rats. Saudi Pharmaceutical Journal, 20(4):365–370.
Al-Shehbaz, I.A., Beilstein, M.A., Kellogg, E.A. 2006. Systematics and phylogeny of the Brassicaceae (Cruciferae): an overview. Plant Systematics and Evolution, 259(2-4):89–120.
Belanger, L., Sylvestre, C., Dufour, D. 1973. Enzyme-linked immunoassay for alpha-fetoprotein by competitive and sandwich procedures. Clinica Chimica Acta, 48(1):90211–90219.
Bergmeyer, H.U., Scheibe, P., Wahlefeld, A.W. 1978. Optimization of methods for aspartate amino-transferase and alanine aminotransferase. Clinical Chemistry, 24(1):58–73.
Boulos 1995. Flora of Egypt Checklist. Al-Hadara Publishing, Cairo, Egypt. pages 38–48.
Boulos 1999. Flora of Egypt, (Azollaceae–Oxalidaceae), vol. 1. Al Hadara Publishing, Cairo, Egypt. 1:35–37.
Chatterjee, R., Mitra, A. 2015. An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer. International Immunopharmacology, 24(2):335–345.
Cohen, G., Dembiec, D., Marcus, J. 1970. Measurement of catalase activity in tissue extracts. Analytical Biochemistry, 34(1):90083–90090.
Doumas, B.T., Watson, W.A., Biggs, H.G. 1997. Albumin standards and the measurement of serum albumin with bromcresol green. Clinica Chimica Acta, 258(1):6447–6456.
Ebos, J.M.L., Kerbel, R.S. 2011. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nature Reviews Clinical Oncology, 8(4):210–221.
Ellis, L.M., Hicklin, D.J. 2008. Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy. Clinical Cancer Research, 14(20):6371–6375.
Gornall, A.G., Bardawill, C.J., David, M.M. 1949. Determination of serum proteins by means of the biuret reaction. The Journal of Biological Chemistry, 177(2):751–766.
Graf, E., Von, T.J., Mabry, K.R., Markham, M.B., Thomas 1970. The Systematic Identification of Flavonoids. Archiv Der Pharmazie, 98(9):715–715. Preis: DM.
Harborne 1984. Phytochemical methods. A guide to modern techniques of plant analysis. New Fetterlan, London. New yourk, pages 142–150. 2nd Ed. Published in.
Hay, R.J. 2000. Cell Line Preservation and Characterization. pages 95–148, Oxford, UK. IRL Press at Oxford University Press. Animal Cell Culture, a Practical Approach.
Kandaswami, C., Kanadaswami, C., Lee, L.T., Lee, P.- P. H., Hwang, J. J., Ke, F.C., Lee, M.T. 2005. The anti-tumor activities of flavonoids. volume 19, pages 895–909, Athens, Greece.
Kim, Y.W., Byzova, T.V. 2014. Oxidative stress in angiogenesis and vascular disease. Blood, 123(5):625–631.
King, E.J., Armstrong, A.R. 1988. Calcium, phosphorus and phosphate. Practical clinical biochemistry, pages 458–458.
Lewi, M. 1981. Toxicological reference data Wistar rat. pages 3–3, Amsterdam. Elsevier/North Holland Biochemical Press.
Li, M., Sen, L.I., Yang, P.F., He, F.Y., Du, S.P., Li, G.G.G. 2002. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Research, 12(2):151–156.
Lu, K., Bhat, M., Basu, S. 2016. Plants and their active compounds: natural molecules to target angiogenesis. Angiogenesis, 19(3):287–295.
Luo, H., Jiang, B.H., King, S.M., Chen, Y.C. 2008. Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids. Nutrition and Cancer, 60(6):800–809.
Marklund, S., Marklund, G. 1974. Involvement of the Superoxide Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay for Superoxide Dismutase. European Journal of Biochemistry, 47(3):469–474.
Marquardt, J.U., Andersen, J.B., Thorgeirsson, S.S. 2015. Functional and genetic deconstruction of the cellular origin in liver cancer. Nature Reviews Cancer, 15(11):653–667.
Mattila, P., Astola, J., Kumpulainen, J. 2000. Determination of Flavonoids in Plant Material by HPLC with Diode-Array and Electro-Array Detections. Journal of Agricultural and Food Chemistry, 48(12):5834–5841.
Meadows, K.L., Hurwitz, H.I. 2012. Anti-VEGF Therapies in the Clinic. Cold Spring Harbor Perspectives in Medicine. 2:6577–006577.
Mekuria, A.N., Abdi, A.D. 2017. Potential molecular targets and drugs for treatment of hepatocellular carcinoma. J Cancer Sci Ther, 9:736–781.
Morse, M.A., Sun, W., Kim, R., He, A.R.A.R., Abada, B.P., Mynderse, M., Richard, S., Finn, R.S. 2019. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res, 25(3).
Oak, M.H., Bedoui, J., Schini-Kerth, V.B. 2005. Antiangiogenic properties of natural polyphenols from red wine and green tea. The Journal of Nutritional Biochemistry, 16(1):1–8.
Olsson, A.K., Dimberg, A., Kreuger, J., Claesson-Welsh, L. 2006. VEGF receptor signalling? in control of vascular function. Nature Reviews Molecular Cell Biology, 7(5):359–371.
Perez, A., Gonzalez-Manzano, S., Jimenez, R., Perez- Abud, R., Haro, J.M., Osuna, A., Perez-Vizcaino, F. 2014. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: Correlation with beta-glucuronidase activity. Pharmacological Research, 89:11–18.
Persijn, J.P., and van der Slik. W 1976. A new method for the determination of gamma-glutamyl transferase in serum. Journal of Clinical Chemistry and Clinical Biochemistry, 14(9):421–427.
Rizk 1986. The Phytochemistry of the Flora of Qatar. pages 582–582.
Satir, A.A. 2007. An update on the pathogenesis and pathology of hepatocellular carcinoma. Bahrain Medical Bulletin, 29(2):1–7.
Simons, M., Gordon, E., Claesson-Welsh, L. 2016. Mechanisms and regulation of endothelial VEGF receptor signalling. Nature Reviews Molecular Cell Biology, 17(10):611–625.
Singh, S., Sharma, B., Kanwar, S.S., Kumar, A. 2016. Lead Phytochemicals for Anticancer Drug Development. Frontiers in Plant Science, 7(1667).
Skehan, P., Storeng, R., Scudiero, D., Monks, A., Mcmahon, J., Vistica, D., Boyd, M.R. 1990. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. JNCI Journal of the National Cancer Institute, 82(13):1107–1112.
Subramanian, P., Mirunalini, S., Dakshayani, K.B., Pandi-Perumal, S.R., Trakht, I., Cardinali, D.P. 2007. Prevention by melatonin of hepatocarcinogenesis in rats injected with N- nitrosodiethylamine. Journal of Pineal Research, 43(3):305–312.
Sullivan, L. A., Brekken, R. A. 2010. The VEGF family in cancer and antibody-based strategies for their inhibition. MAbs, 2(2):165–175.
Verna, L., Whysner, J., Williams, G.M. 1996. N-Nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacology & Therapeutics, 71(1):62–71.
Walter, M., Gerade, R.W. 1970. Bilirubin direct/total. Microchemical Journal, 15:231–233.
Weber, L.W.D., Boll, M., Stampfl, A. 2003. Hepato-toxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model. Critical Reviews in Toxicology, 33(2):105–136.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.